TRAF6 and cancer: Experiments using either xenograft or genetic mouse models illustrated that deficiency in Skp2, TRAF6 or TRAF4 results in suppression of cancer development in vivo, pointing to the critical role of distinct E3 ubiquitin ligases in Akt-mediated biological functions and cancer progression.